Companies / Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

Nasdaq: AXSMCIK 1579428NEW YORK, NY
Insider flow · last 90 daysNet sells $12.11M

Financials · FY2025

Revenue$638.50M
Net income$-183.17M
Total debt$117.96M
Cash$319.85M
Diluted EPS$-3.68
Shares outstanding52.4M

Ownership

52.4M shares outstanding · as of Aug 3, 2026
0.32%Insiders
Ownership
Insiders0.32%166,755
Institutions72.03%37,732,282
Public float27.65%14,481,781

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Jeffs RogerDirector
0.11%58,367
Coleman MarkDirector
0.09%47,140
Pizzie NickChief Financial Officer
0.08%42,588
Saad Mark EDirector
0.02%11,431
Tabuteau HerriotCEOChief Executive Officer · Director · 10% owner
0.01%7,229
Jacobson Mark L.Chief Operating Officer
0.00%0
Maizel AriChief Commercial Officer
0.00%0
Murdock Hunter R.General Counsel
——

Institutional holders 408

View all →
HolderValue% of shares
Vanguard Group Inc$760.66M7.95%
BlackRock, Inc.$759.69M5.93%
Invesco Ltd.$232.59M2.43%
Wellington Management Group LLP$223.12M2.33%
Fmr LLC$215.81M2.26%
Deep Track Capital, LP$210.04M2.20%
Geode Capital Management, LLC$196.60M2.22%
State Street Corporation$192.29M1.50%
Nomura Asset Management International Inc.$180.71M1.89%
RTW Investments, LP$162.18M1.70%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 5, 2026Tabuteau Herriot
CEO
SellCommon Stock$13.48M-79K
-91.59%
7,229
0.01% of shares
high
Jun 9, 2026Tabuteau Herriot
CEO
SellCommon Stock$11.97M-50K
-87.30%
7,229
0.01% of shares
high
Feb 2, 2026Tabuteau Herriot
CEO
SellCommon Stock$6.02M-32K
-81.76%
7,229
0.01% of shares
medium
Feb 26, 2026Jacobson Mark L.
Executive
SellCommon Stock$5.73M-35K
-100.00%
0
0.00% of shares
medium
Jan 7, 2026Tabuteau Herriot
CEO
SellCommon Stock$5.33M-31K
-81.22%
7,229
0.01% of shares
medium
Dec 31, 2025Saad Mark E
Director
SellCommon Stock$5.18M-31K
-75.81%
10,002
0.02% of shares
medium
Jan 6, 2026Tabuteau Herriot
CEO
SellCommon Stock$5.08M-29K
-80.29%
7,229
0.01% of shares
medium
Feb 26, 2026Coleman Mark
Director
SellCommon Stock$4.03M-25K
-34.65%
47,140
0.09% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AXSM——05464T104—